Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: Clinicopathologic significance and genetic background

Clinical Cancer Research

Volumn 12, Issue 21, 2006, Pages 6469-6479

  Tajima, Yusuke ^a   Yamazaki, Kimiyasu ^a   Makino, Reiko ^a   Nishino, Nobukazu ^a   Aoki, Shigeo ^a   Kato, Masanori ^a   Morohara, Koji ^a   Kaetsu, Tsutomu ^a   Kusano, Mitsuo ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; K RAS PROTEIN; MUCIN; MUCIN 6; PROTEIN P53; TUMOR MARKER;

ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CONTROLLED STUDY; FOLLOW UP; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

ADENOMA; DNA MUTATIONAL ANALYSIS; GASTRIC MUCIN; GENES, APC; GENES, P53; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MUCINS; MUTATION; NEPRILYSIN; PHENOTYPE; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33751292686     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-1339     Document Type: Article

References (39)

1. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histologenesis and histological appearances. Jpn J Cancer Res 1968;59:251-8.
2. Lauren P. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
3. Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol 1996;23:307-15.
4. Tatematsu M, Ichinose N, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990;40:494-504.
5. Egashira Y, Shimoda T, Ikegami M. Muchin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 1999;49:55-61.
6. Sasaki I, Yao T, Nawata H, Tsuneyoshi M. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development. Cancer 1999;85:1719-29.
7. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G. Histologic heterogeneity and phenotypic expression in early gastric cancer. Pathol Int 2001;51:165-71.
8. Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M. Relationship between biological behavior and phenotypic expression in intramucosal gastric carcinoma. Hum Pathol 2002;33:80-6.
9. Shibata N, Watari J, Fujiya M, Tanno S, Saitoh Y, Kohgo Y. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol 2003;34:32-40.
10. Endoh Y, Jamura G, Watanabe H, Ajioka Y, Motoyama T. The common 18-base pair deletion at codons 418-423 of the E-cadherin gene in differentiated-type adenocarcinomas and intramucosal precancerous lesions of the stomach with the features of gastric foveolar epithelium. J Pathol 1999;189:201-6.
11. Endoh Y, Sakata K, Tamura G, et al. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000;191:257-63.
12. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000;89:724-32.
13. Tajima Y, Shimoda T, Nakanishi Y, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 2001;61:212-20.
14. Tsukashita S, Kushima R, Bamba M, Sugihara H, Hattori T. MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer 2001;94:166-70.
15. Tajima Y, Shimoda T, Nakanishi Y, et al. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil. J Cancer Res Clin Oncol 2003;129:683-90.
16. Tajima Y, Yamazaki K, Nishino N, et al. Gastric and intestinal phenotypic marker expression in gastric carcinoma and recurrence pattern after surgery: immunohistochemical analysis of 213 lesions. Br J Cancer 2004;91:1342-8.
17. Yamazaki K, Tajima Y, Makino R, et al. Tumor differentiation pnenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol 2006;12:3803-9.
18. Yamachika T, Inada K, Fijimitsu Y, et al. Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch 1997;431:103-10.
19. Yoshikawa A, Inada K, Yamachika T, Shimizu N, Kaminishi M, Tatematsu M. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1998;1:134-41.
20. Morohara K, Tajima Y, Nakao K, et al. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes. J Cancer Res Clin Oncol 2006;132:363-75.
21. Stadtlander CT, Waterbor JW. Molecular epidemiology, pathogenesis, and prevention of gastric cancer. Carcinogenesis 1999;20:2195-208.
22. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
23. Bara J, Chastre E, Mahiou J, et al. Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer 1998;75:767-73.
24. Nollet S, Forgue-Lafitte ME, Kirkham P, Bara J. Mapping of two new epitopes on the apomucin encoded by MUC5AC gene: expression in normal GI tract and colon tumors. Int J Cancer 2002;99:336-43.
25. De Bolos C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 1995;109:723-34.
26. Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct pattern of mucin (MUIC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999;59:1003-7.
27. Kim YS, Gum JR. Diversity of mucin genes, structure, function, and expression. Gastroenterology 1995;109:999-1013.
28. Ronco P, Allegri L, Melcion C, et al. A monoclonal antibody to brush border and passive nephritis. Clin Exp Immunol 1984;55:319-32.
29. Trejdosiewicz LK, Malizia G, Oakes J, Losowsky MS, Janossy G. Expression of common acute lymphoblastic leukaemia antigen (CALLA gp100) in the brush border of normal jejunum and jejunum of patients with coeliac disease. J Clin Pathol 1985;38:1002-6.
30. Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
31. Konishi K, Yamochi T, Makino R, et al. Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin Cancer Res 2004;10:3082-90.
32. Lee JH, Abraham SC, Kim HS, et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 2002;161:611-8.
33. Hiyama T, Haruma K, Kitadai Y, et al. K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer 2002;91:562-6.
34. Makino R, Kaneko K, Kurahashi T, Matsumura T, Mitamura K. Detection of mutation p53 gene with high sensitivity by fluorescence-based PCR-SSCP analysis using low-pH buffer and an automated DNA sequencer in a large number of DNA samples. Mutat Res 2000;452:83-90.
35. Baba S, Kukita Y, Higasa K, Tahira T, Hayashi K. Single-stranded conformational polymorphism analysis using automated capillary array electrophoresis apparatus. Biotechniques 2003;34:746-50.
36. Tamura G, Maesawa C, Suzuki Y, et al. Mutations of the APC gene occur during early stages of gastric adenoma development. Cancer Res 1994;54:1149-51.
37. Vogelstein B, Fearon FR, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1998;319:525-32.
38. Rugge M, Cassaro M, Di Mario F, et al. Interdisciplinary Group on Gastric Epithelial Dysplasia (IGGED). The long term outcome of gastric non-invasive neoplasia. Gut 2003;52:1111-6.
39. Inada K, Nakanishi H, Fujimitsu Y, et al. Gastric and intestinal mixed and solely intestinal types of intestinal metaplasia in the human stomach. Pathol Int 1997;47:831-41.